OM vs. ZYXI, AXGN, EDAP, SMLR, ELMD, FONR, VANI, HYPR, ECOR, and CUTR
Should you be buying Outset Medical stock or one of its competitors? The main competitors of Outset Medical include Zynex (ZYXI), AxoGen (AXGN), Edap Tms (EDAP), Semler Scientific (SMLR), Electromed (ELMD), FONAR (FONR), Vivani Medical (VANI), Hyperfine (HYPR), electroCore (ECOR), and Cutera (CUTR). These companies are all part of the "electromedical equipment" industry.
Outset Medical (NASDAQ:OM) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership, earnings and community ranking.
Zynex has higher revenue and earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.
Outset Medical presently has a consensus target price of $5.42, suggesting a potential upside of 45.22%. Zynex has a consensus target price of $18.00, suggesting a potential upside of 77.34%. Given Zynex's stronger consensus rating and higher probable upside, analysts clearly believe Zynex is more favorable than Outset Medical.
29.7% of Zynex shares are owned by institutional investors. 3.5% of Outset Medical shares are owned by company insiders. Comparatively, 52.1% of Zynex shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
In the previous week, Outset Medical and Outset Medical both had 1 articles in the media. Zynex's average media sentiment score of 1.44 beat Outset Medical's score of 1.42 indicating that Zynex is being referred to more favorably in the news media.
Outset Medical has a beta of 1.85, indicating that its share price is 85% more volatile than the S&P 500. Comparatively, Zynex has a beta of 0.49, indicating that its share price is 51% less volatile than the S&P 500.
Zynex has a net margin of 4.33% compared to Outset Medical's net margin of -134.93%. Zynex's return on equity of 16.34% beat Outset Medical's return on equity.
Outset Medical and Zynex both received 22 outperform votes by MarketBeat users. However, 51.16% of users gave Zynex an outperform vote while only 37.93% of users gave Outset Medical an outperform vote.
Summary
Zynex beats Outset Medical on 14 of the 16 factors compared between the two stocks.
Get Outset Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for OM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Outset Medical Competitors List
Related Companies and Tools
